These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 24241057)

  • 1. Dynamic resistant hypertension patterns as predictors of cardiovascular morbidity: a 4-year prospective study.
    Tsioufis C; Kasiakogias A; Kordalis A; Dimitriadis K; Thomopoulos C; Tsiachris D; Vasileiou P; Doumas M; Makris T; Papademetriou V; Kallikazaros I; Bakris G; Stefanadis C
    J Hypertens; 2014 Feb; 32(2):415-22. PubMed ID: 24241057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stroke and coronary heart disease in treated hypertension -- a prospective cohort study over three decades.
    Almgren T; Persson B; Wilhelmsen L; Rosengren A; Andersson OK
    J Intern Med; 2005 Jun; 257(6):496-502. PubMed ID: 15910553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left ventricular hypertrophy versus chronic kidney disease as predictors of cardiovascular events in hypertension: a Greek 6-year-follow-up study.
    Tsioufis C; Vezali E; Tsiachris D; Dimitriadis K; Taxiarchou E; Chatzis D; Thomopoulos C; Syrseloudis D; Stefanadi E; Mihas C; Katsi V; Papademetriou V; Stefanadis C
    J Hypertens; 2009 Apr; 27(4):744-52. PubMed ID: 19516174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic importance of baseline and serial changes in microalbuminuria in patients with resistant hypertension.
    Salles GF; Cardoso CR; Fiszman R; Muxfeldt ES
    Atherosclerosis; 2011 May; 216(1):199-204. PubMed ID: 21315356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Resistant arterial hypertension in Primary Care patients in Spain. PRESCAP Study 2010].
    Cinza-Sanjurjo S; Alonso-Moreno FJ; Prieto-Díaz MÁ; Divisón-Garrote JA; Rodríguez-Roca GC; Llisterri-Caro JL;
    Semergen; 2015 Apr; 41(3):123-30. PubMed ID: 24768029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular morbidity of severe resistant hypertension among treated uncontrolled hypertensives: a 4-year follow-up study.
    Kasiakogias A; Tsioufis C; Dimitriadis K; Konstantinidis D; Koumelli A; Leontsinis I; Andrikou E; Vogiatzakis N; Marinaki S; Petras D; Fragoulis C; Konstantinou K; Papademetriou V; Tousoulis D
    J Hum Hypertens; 2018 Jul; 32(7):487-493. PubMed ID: 29713047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visfatin levels are increased in patients with resistant hypertension and are correlated with left ventricular hypertrophy.
    Ozal E; Sahin I; Bolat I; Pusuroglu H; Avci II; Akgul O; Ornek V; Sürgit O; Yildirim A
    Blood Press Monit; 2017 Jun; 22(3):137-142. PubMed ID: 28240682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of a reduced glomerular filtration rate and interaction with microalbuminuria in resistant hypertension: a cohort study.
    Salles GF; Cardoso CR; Pereira VS; Fiszman R; Muxfeldt ES
    J Hypertens; 2011 Oct; 29(10):2014-23. PubMed ID: 21873887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between gender and clinical characteristics, associated factors, and hypertension treatment in patients with resistant hypertension.
    Hanus KM; Prejbisz A; Gąsowski J; Klocek M; Topór-Mądry R; Leśniak W; Kabat M; Czarnecka D; Kawecka-Jaszcz K; Narkiewicz K; Januszewicz A
    Kardiol Pol; 2017; 75(5):421-431. PubMed ID: 28150289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of baseline and serial changes in electrocardiographic strain pattern in resistant hypertension.
    Salles GF; Cardoso CR; Fiszman R; Muxfeldt ES
    J Hypertens; 2010 Aug; 28(8):1715-23. PubMed ID: 20520577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of changes in the electrocardiographic strain pattern during antihypertensive treatment: the Losartan Intervention for End-Point Reduction in Hypertension Study (LIFE).
    Okin PM; Oikarinen L; Viitasalo M; Toivonen L; Kjeldsen SE; Nieminen MS; Edelman JM; Dahlöf B; Devereux RB;
    Circulation; 2009 Apr; 119(14):1883-91. PubMed ID: 19332468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular outcomes in hypertensive patients: comparing single-agent therapy with combination therapy.
    Weber MA; Julius S; Kjeldsen SE; Jia Y; Brunner HR; Zappe DH; Hua TA; McInnes GT; Schork A; Mancia G; Zanchetti A
    J Hypertens; 2012 Nov; 30(11):2213-22. PubMed ID: 23011525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sleep-time blood pressure: prognostic value and relevance as a therapeutic target for cardiovascular risk reduction.
    Hermida RC; Ayala DE; Fernández JR; Mojón A
    Chronobiol Int; 2013 Mar; 30(1-2):68-86. PubMed ID: 23181592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertension in middle-aged men. Management, morbidity and prognostic factors during long-term hypertensive care.
    Samuelsson O
    Acta Med Scand Suppl; 1985; 702():1-79. PubMed ID: 3866485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level--the "normotensive non-dipper" paradox.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):87-98. PubMed ID: 23039824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence, predictors, and outcomes in treatment-resistant hypertension in patients with coronary disease.
    Bangalore S; Fayyad R; Laskey R; Demicco DA; Deedwania P; Kostis JB; Messerli FH;
    Am J Med; 2014 Jan; 127(1):71-81.e1. PubMed ID: 24210549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood pressure levels, risk factors and antihypertensive treatments: lessons from the SHEAF study.
    Mallion JM; Genès N; Vaur L; Clerson P; Vaïsse B; Bobrie G; Chatellier G
    J Hum Hypertens; 2001 Dec; 15(12):841-8. PubMed ID: 11773986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary albumin excretion at follow-up predicts cardiovascular outcomes in subjects with resistant hypertension.
    Oliveras A; Armario P; Sierra C; Arroyo JA; Hernández-del-Rey R; Vazquez S; Larrousse M; Sans L; Roca-Cusachs A; de la Sierra A
    Am J Hypertens; 2013 Sep; 26(9):1148-54. PubMed ID: 23747954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of lower achieved blood pressure on outcomes in hypertensive patients.
    Okin PM; Hille DA; Kjeldsen SE; Dahlöf B; Devereux RB
    J Hypertens; 2012 Apr; 30(4):802-10; discussion 810. PubMed ID: 22343536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.